 |
|
Clinical and genetic characteristics of Korean autosomal dominant polycystic kidney disease patients
Yun Kyu Oh, Hayne Cho Park, Hyunjin Ryu, Yong-Chul Kim, Kook-Hwan Oh
Korean J Intern Med. 2021;36(4):767-779. Published online 2021 Jul 1 DOI: https://doi.org/10.3904/kjim.2021.176
|
|
Citations to this article as recorded by
 Clinical manifestation, epidemiology, genetic basis, potential molecular targets, and current treatment of polycystic liver disease
Amir Ali Mahboobipour, Moein Ala, Javad Safdari Lord, Arash Yaghoobi
Orphanet Journal of Rare Diseases.2024;[Epub] CrossRef Novel Potential Therapeutic Targets in Autosomal Dominant Polycystic Kidney Disease from the Perspective of Cell Polarity and Fibrosis
Yejin Ahn, Jong Hoon Park
Biomolecules & Therapeutics.2024; 32(3): 291. CrossRef Acyl-CoA thioesterase 13 (ACOT13) attenuates the progression of autosomal dominant polycystic kidney disease in vitro via triggering mitochondrial-related cell apoptosis
Bin Wang, Qi Yang, Lihe Che, Luyao Sun, Na Du
Aging.2024; 16(16): 11877. CrossRef Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease
Yaerim Kim, Seungyeup Han
The Korean Journal of Internal Medicine.2023; 38(3): 322. CrossRef Clinical Characteristics of Rapid Progression in Asia-Pacific Patients With ADPKD
Yun Kyu Oh, Hyunjin Ryu, Curie Ahn, Hayne C. Park, Yiyi Ma, Dechao Xu, Tevfik Ecder, Tze-Wah Kao, Jeng-Wen Huang, Gopala K. Rangan, Yun Kyu Oh, Hyunjin Ryu, Curie Ahn, Hayne C. Park, Yiyi Ma, Dechao Xu, Changlin Mei, Tevfik Ecder, Angela Yee-Moon Wang, Tz
Kidney International Reports.2023; 8(9): 1801. CrossRef Validation of prediction algorithm for risk estimation of intracranial aneurysm development using real-world data
Tackeun Kim, Jisu Choi, Won-Ju Park, Seunghyeon Cho, Yeongjae Yoo, Hyeonjun Kim, Juhee Cho, Jin-Deok Joo, Chang Wan Oh
Scientific Reports.2023;[Epub] CrossRef Mayo imaging classification is a good predictor of rapid progress among Korean patients with autosomal dominant polycystic kidney disease: results from the KNOW-CKD study
Hayne Cho Park, Yeji Hong, Jeong-Heum Yeon, Hyunjin Ryu, Yong-Chul Kim, Joongyub Lee, Yeong Hoon Kim, Dong-Wan Chae, WooKyung Chung, Curie Ahn, Kook-Hwan Oh, Yun Kyu Oh
Kidney Research and Clinical Practice.2022; 41(4): 432. CrossRef Clinical and genetic study of a Chinese family affected by both amyotrophic lateral sclerosis and autosomal dominant polycystic kidney disease
Shirong Li, Junyu Lin, Chunyu Li, Yongping Chen, Bei Cao, Tianmi Yang, Qianqian Wei, Bi Zhao, Xueping Chen, Huifang Shang
Frontiers in Neurology.2022;[Epub] CrossRef Practical Issues in the Management of Polycystic Kidney Disease: Blood Pressure and Water Balance
Hayne Cho Park, Yun Kyu Oh
Electrolytes & Blood Pressure.2022; 20(1): 10. CrossRef Predicting the number of citations of polycystic kidney disease with 100 top-cited articles since 2010: Bibliometric analysis
Chen-Yu Wang, Tsair-Wei Chien, Willy Chou, Hsien-Yi Wang
Medicine.2022; 101(38): e30632. CrossRef
|